Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Arbutus Biopharma Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 111 | 1 | 99 | −11 |
| Shares | 66.2M | 300 | 70.8M | +4.61M (+7.0%) |
| Value | $152.4M | $690 | $143.8M | −$8.59M (−5.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Centiva Capital, LP | 1,071,705 | $2.18M | 0.11% |
| SG Americas Securities, LLC | 40,055 | $81.0K | 0.00% |
| Kades & Cheifetz LLC | 20,000 | $40.6K | 0.03% |
| Caption Management, LLC | 2,671 | $5.42K | 0.00% |
| Quadrant Capital Group LLC | 912 | $1.85K | 0.00% |
Sold out (16)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Rubric Capital Management LP | 3,395,855 | $7.81M |
| Primecap Management Co | 328,100 | $754.6K |
| Renaissance Technologies LLC | 321,128 | $739.0K |
| DekaBank Deutsche Girozentrale | 150,000 | $331.0K |
| Gsa Capital Partners LLP | 36,923 | $85.0K |
| Man Group plc | 24,500 | $56.4K |
| Prelude Capital Management, LLC | 18,790 | $43.2K |
| Two Sigma Advisers, LP | 13,700 | $31.5K |
| Credit Agricole S A | 7,750 | $17.8K |
| Lindbrook Capital, LLC | 833 | $1.92K |
| Allworth Financial LP | 440 | $1.01K |
| Richard W. Paul & Associates, LLC | 379 | $872 |
| Key Financial Inc | 322 | $741 |
| Allspring Global Investments Holdings, LLC | 95 | $218 |
| Crewe Advisors LLC | 56 | $129 |
| GWM Advisors LLC | 10 | $23 |
Not filed for Q3 2023 yet (1)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Coastal Capital Group, Inc. | 300 | $690 |